A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men

被引:17
作者
Bhambhvani, Hriday P. [1 ]
Kasman, Alex M. [1 ]
Wilson-King, Genester [2 ]
Eisenberg, Michael L. [1 ]
机构
[1] Stanford Univ, Dept Urol, Med Ctr, 300 Pasteur Dr, Stanford, CA 94305 USA
[2] Victory Rejuvenat Ctr, Lake Mary, FL USA
来源
SEXUAL MEDICINE | 2020年 / 8卷 / 03期
关键词
Cannabis; Orgasm; Erectile dysfunction; SHIM; INTERNATIONAL INDEX; MARIJUANA USE; DYSFUNCTION; PREVALENCE; ALCOHOL; IMPACT;
D O I
10.1016/j.esxm.2020.06.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Cannabis is the most commonly used drug in the United States; however, the effects of cannabis use on male sexual function are poorly understood. Aim: To characterize the contemporary landscape of cannabis use and to assess the associations between male sexual function and the frequency of use, the primary method of consumption, or cannabis chemovar (tetrahydrocannabinol or cannabidiol) among current users. Methods: We surveyed adults who visited a single cannabis dispensary for baseline demographic information, medical history, cannabis use habits, and sexual function as assessed by the International Index of Erectile Function (IIEF). An IIEF-5 < 21 was considered erectile dysfunction. Main Outcome Measures: The main outcome measure of the study was male sexual function via the IIEF domain scores. Results: A total of 325 men completed the survey with a mean age of 46.7 years. 71.1% of the men were Caucasian and 52.6% were married. 13 men (4%) were never users; 29 men (8.9%) used 1-2 times/week; 51 men (15.7%) used 3-5 times/week, and 232 men (71.4%) used 6+ times/week. The average IIEF-5 score was 22.3 with 19.4% of the men having erectile dysfunction. In univariate analysis, men using cannabis more frequently had a higher overall IIEF (65.36 vs 60.52, P = .001), erectile domain (27.32 vs 25.74, P = .03), orgasm domain (9.08 vs 8.12, P < .001), intercourse satisfaction domain (12.42 vs 11.31, P = .006), and overall satisfaction domain (8.11 vs 7.05, P = .002). In multivariable analysis, compared to men who used cannabis 0 times/week, those who used 6 times/week had an increased overall IIEF (69.08 vs 64.64, P-value adjusted = 0.02), intercourse satisfaction domain (P-value adjusted = 0.04), and overall satisfaction domain (P-value adjusted = 0.02). The primary method of consumption (eg, smoking, edibles, etc.) and cannabinoid composition (eg, cannabidiol vs tetrahydrocannabinol dominant) were not associated with sexual function. Conclusion: We report an association between the increased frequency of cannabis use and increased male sexual function. However, while the increased frequency of use was statistically significant with regard to the IIEF scores, the clinical significance of this is likely low, and selection bias may limit the generalizability of these findings. The method of consumption and cannabis chemovar were not associated with sexual function. Bhambhvani HP, Kasman AM, Wilson-King G, et al. A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men. J Sex Med 2020;8:436-445. Copyright (c) 2020, The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:436 / 445
页数:10
相关论文
共 29 条
  • [1] A controlled study of sexual function in men with cannabis use disorder: A brief report
    Aldemir, Ebru
    Akyel, Betul
    Gokcelli, Duygu Keskin
    Celikay, Hande
    Altintoprak, A. Ender
    Coskunol, Hakan
    [J]. JOURNAL OF SUBSTANCE USE, 2017, 22 (05) : 490 - 493
  • [2] Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study
    Androvicova, R.
    Horacek, J.
    Tintera, J.
    Hlinka, J.
    Rydlo, J.
    Jezova, D.
    Balikova, M.
    Hlozek, T.
    Miksatkova, P.
    Kuchar, M.
    Roman, M.
    Tomicek, P.
    Tyls, F.
    Viktorinova, M.
    Palenicek, T.
    [J]. PSYCHOPHARMACOLOGY, 2017, 234 (13) : 1933 - 1943
  • [3] [Anonymous], 2018, KEY SUBST US MENT HL
  • [4] Cannabis, a complex plant: different compounds and different effects on individuals
    Atakan, Zerrin
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) : 241 - 254
  • [5] Azofeifa A, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6511a1
  • [6] Pleasure Systems in the Brain
    Berridge, Kent C.
    Kringelbach, Morten L.
    [J]. NEURON, 2015, 86 (03) : 646 - 664
  • [7] Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
    Bhattacharyya, Sagnik
    Morrison, Paul D.
    Fusar-Poli, Paolo
    Martin-Santos, Rocio
    Borgwardt, Stefan
    Winton-Brown, Toby
    Nosarti, Chiara
    O'Carroll, Colin M.
    Seal, Marc
    Allen, Paul
    Mehta, Mitul A.
    Stone, James M.
    Tunstall, Nigel
    Giampietro, Vincent
    Kapur, Shitij
    Murray, Robin M.
    Zuardi, Antonio W.
    Crippa, Jose A.
    Atakan, Zerrin
    McGuire, Philip K.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2010, 35 (03) : 764 - 774
  • [8] Anandamide Transforms Noncopulating Rats into Sexually Active Animals
    Canseco-Alba, Ana
    Rodriguez-Manzo, Gabriela
    [J]. JOURNAL OF SEXUAL MEDICINE, 2013, 10 (03) : 686 - 693
  • [9] Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice
    Carvalho, Renata K.
    Souza, Maingredy R.
    Santos, Monaliza L.
    Guimaraes, Francisco S.
    Pobbe, Roger Luis H.
    Andersen, Monica L.
    Mazaro-Costa, Renata
    [J]. REPRODUCTIVE TOXICOLOGY, 2018, 81 : 34 - 40
  • [10] Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries
    Chapel, John M.
    Ritchey, Matthew D.
    Zhang, Donglan
    Wang, Guijing
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (06) : S143 - S154